Onxeo Announces Enrollment of First Patient in Phase Ib/II Study Revocan

Ads

You May Also Like

DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients

Press ReleaseMontrouge, France, February 26, 2018                                                                                                                                                                           DBV Technologies Announces Results from Phase ...